Kudou et al. also found that AQP5 inhibition impedes HCC metastasis and EMT via deactivation of the NF-кB signaling pathway [176], while Yang et al. observed that Topotecan negatively regulates AQP5 and NF-kB activity [154]. This evidence concerns the gene AQP5 and hepatocellular carcinoma.